EXTRAORDINARY GENERAL MEETING IN KARO PHARMA AKTIEBOLAG ON 20 SEPTEMBER 2019
STOCKHOLM, 20 September 2019At today’s extraordinary general meeting in Karo Pharma, the following resolution was passed.The general meeting resolved, in accordance with the Board of Directors’ proposal, to authorize the Board of Directors to, on one or several occasions until the Annual General Meeting 2020, resolve on a new issue of shares with pre-emption rights for the company’s shareholders. The total number of shares that may be issued by virtue of the authorization shall be within the limits of the share capital as set forth in the articles of association. Other share issue terms